{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:05:34Z","timestamp":1776380734256,"version":"3.51.2"},"reference-count":44,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation of South Africa","award":["112980"],"award-info":[{"award-number":["112980"]}]},{"name":"National Research Foundation of South Africa","award":["145396"],"award-info":[{"award-number":["145396"]}]},{"name":"South African Medical Research Council through its Division of Research Capacity Development under the Early Investigators Programme awarded to OJP","award":["112980"],"award-info":[{"award-number":["112980"]}]},{"name":"South African Medical Research Council through its Division of Research Capacity Development under the Early Investigators Programme awarded to OJP","award":["145396"],"award-info":[{"award-number":["145396"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Antimicrobial drug resistance in Neisseria gonorrhoeae has been documented all over the world. However, the situation in Sub-Saharan Africa has received little attention. It is critical to establish diagnostics and extend surveillance in order to prevent the emergence of illnesses that are resistant to several treatments. Monitoring antimicrobial susceptibility is critically required in order to gather data that may be utilised to produce treatment recommendations that will result in effective therapy, a decrease in gonorrhoeae-related difficulties and transmission, and effective therapy. Government authorities may set research and preventive objectives, as well as treatment recommendations, using data from the Gonococcal Antimicrobial Surveillance Program (GISP). Local and state health authorities may use GISP data to make choices about the allocation of STI prevention services and resources, to guide preventative planning, and to disseminate information about the most successful treatment practices. Using molecular and culture approaches, we investigated the occurrence of antibiotic resistance in isolates from KwaZulu Natal, South Africa. The great majority of gonococcal isolates (48% showed absolute resistance to ciprofloxacin), with penicillin and tetracycline resistance rates of 14% each. Only one of the gonococcal isolates tested positive for azithromycin resistance, with a minimum inhibitory concentration (MIC) of 1.5 \u00b5g\/mL. Ceftriaxone was effective against all gonococcal isolates tested.<\/jats:p>","DOI":"10.3390\/medsci11020028","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T10:19:33Z","timestamp":1680257973000},"page":"28","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of Emerging Multidrug-Resistant Neisseria gonorrhoeae Isolates against Five Major Antimicrobial Agent Options"],"prefix":"10.3390","volume":"11","author":[{"given":"Sinethemba Hopewell","family":"Yakobi","sequence":"first","affiliation":[{"name":"School of Life Sciences, Biochemistry, University of KwaZulu-Natal, Durban 3629, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2967-7846","authenticated-orcid":false,"given":"Ofentse Jacob","family":"Pooe","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Biochemistry, University of KwaZulu-Natal, Durban 3629, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2016). WHO Guidelines for the Treatment of Neisseria gonorrhoeae, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/bacteria1020009","article-title":"Antimicrobial Resistance of Neisseria gonorrhoeae in Sub-Saharan Populations","volume":"1","author":"Yakobi","year":"2022","journal-title":"Bacteria"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Unemo, M. (2015). Current and future antimicrobial treatment of gonorrhoea\u2014The rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-1029-2"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.34297\/AJBSR.2022.16.002220","article-title":"Gonococcal Ophthalmia Neonatorum Infection Transmitted at Birth","volume":"16","author":"Yakobi","year":"2022","journal-title":"Am. J. Biomed. Sci. Res."},{"key":"ref_5","unstructured":"P\u00e9rez-Gracia, M.T., and Suay-Garc\u00eda, B. (2021). Diagnostics to Pathogenomics of Sexually Transmitted Infections, John Wiley & Sons."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Jacobsson, S., Cole, M.J., Spiteri, G., Day, M., Unemo, M., Eder, C., Pleininger, S., Indra, A., Huhlescu, S., and De Baetselier, I. (2021). Associations between antimicrobial susceptibility\/resistance of Neisseria gonorrhoeae isolates in European Union\/European Economic Area and patients\u2019 gender, sexual orientation and anatomical site of infection, 2009\u20132016. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-05931-0"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1473-3099(19)30116-1","article-title":"Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): A randomised phase 3 non-inferiority trial","volume":"19","author":"Chen","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Suay-Garc\u00eda, B., and P\u00e9rez-Gracia, M.T. (2018). Future Prospects for Neisseria gonorrhoeae Treatment. Antibiotics, 7.","DOI":"10.20944\/preprints201805.0315.v1"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e00906-20","DOI":"10.1128\/AAC.00906-20","article-title":"Antimicrobial Resistance of Neisseria gonorrhoeae Isolates from High-Risk Men in Johannesburg, South Africa","volume":"64","author":"Maduna","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.21037\/atm.2018.06.28","article-title":"MALDI-TOF mass spectrometry technology for detecting biomarkers of antimicrobial resistance: Current achievements and future perspectives","volume":"6","author":"Vrioni","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1874613601610010034","article-title":"HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities","volume":"10","author":"Kharsany","year":"2016","journal-title":"Open AIDS J."},{"key":"ref_12","unstructured":"Abeyewickreme, I., and World Health Organization (2012). World Health Organization, Reproductive Health and Research. Strategies and Laboratory Methods for Strengthening Surveillance of Sexually Transmitted Infection, 2012, World Health Organization."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kularatne, R., Maseko, V., Gumede, L., and Kufa, T. (2018). Trends in Neisseria gonorrhoeae Antimicrobial Resistance over a Ten-Year Surveillance Period, Johannesburg, South Africa, 2008\u20132017. Antibiotics, 7.","DOI":"10.3390\/antibiotics7030058"},{"key":"ref_14","unstructured":"Peters, R., and Maduna, L.D. (2021, September 14). Drug-Resistant Gonorrhoea Is a Growing Threat: A South African Case Study. Available online: https:\/\/theconversation.com\/drug-resistant-gonorrhoea-is-a-growing-threat-a-south-african-case-study-148012."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1038\/s41467-020-17980-1","article-title":"Adaptation to the cervical environment is associated with increased antibiotic susceptibility in Neisseria gonorrhoeae","volume":"11","author":"Ma","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1071\/SH19061","article-title":"Epidemiology of Gonorrhea: A Global Perspective","volume":"16","author":"Kirkcaldy","year":"2019","journal-title":"Sex. Health"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Meyer, T., and Buder, S. (2020). The Laboratory Diagnosis of Neisseria gonorrhoeae: Current Testing and Future Demands. Pathogens, 9.","DOI":"10.3390\/pathogens9020091"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.14745\/ccdr.v45i23a02","article-title":"Multidrug resistant gonorrhea: Addressing the rising rates of gonorrhea and drug-resistant gonorrhea: There is no time like the present","volume":"45","author":"Bodie","year":"2019","journal-title":"Canada Commun. Dis. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance\u2014The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014","volume":"65","author":"Kirkcaldy","year":"2019","journal-title":"MMWR. Surveill. Summ."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e02313-18","DOI":"10.1128\/AAC.02313-18","article-title":"Emergence of Neisseria gonorrhoeae Strains Harboring a Novel Combination of Azithromycin-Attenuating Mutations","volume":"63","author":"Pham","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41585-021-00534-5","article-title":"Outer membrane vesicle vaccines for Neisseria gonorrhoeae","volume":"19","author":"Semchenko","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Torrone, E.A., Morrison, C.S., Chen, P.L., Kwok, C., Francis, S.C., Hayes, R.J., Looker, K.J., McCormack, S., McGrath, N., and van de Wijgert, J.H.H.M. (2018). Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002511"},{"key":"ref_23","first-page":"56","article-title":"Neisseria gonorrhoeae antimicrobial resistance surveillance in Gauteng Province, South Africa","volume":"14","author":"Kularatne","year":"2016","journal-title":"Commun. Dis. Surveill. Bull."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7196\/SAMJ.2021.v111i2.14905","article-title":"Causative pathogens and antibiotic resistance in community-acquired urinary tract infections in central South Africa","volume":"111","author":"Fourie","year":"2021","journal-title":"SAMJ S. Afr. Med. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fpubh.2019.00004","article-title":"Does male circumcision reduce women\u2019s risk of sexually transmitted infections, cervical cancer, and associated conditions?","volume":"7","author":"Morris","year":"2019","journal-title":"Front. Public Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40265-021-01530-0","article-title":"Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions","volume":"81","author":"Lin","year":"2021","journal-title":"Drugs"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1099\/jmm.0.001172","article-title":"Repurposing bioactive compounds for treating multidrug-resistant pathogens","volume":"69","author":"Hummell","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/mdr.2017.0054","article-title":"In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates","volume":"24","author":"Hamasuna","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kivata, M.W., Mbuchi, M., Eyase, F., Bulimo, W.D., Kyanya, C.K., Oundo, V., Mbinda, W.M., Sang, W., Andagalu, B., and Soge, O.O. (2020). Plasmid mediated penicillin and tetracycline resistance among Neisseria gonorrhoeae isolates from Kenya. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05398-5"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/OLQ.0000000000000929","article-title":"Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection\u2014Clinical Trial Group Programmatic Meeting","volume":"46","author":"Cristillo","year":"2019","journal-title":"Sex. Transm. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/OLQ.0000000000000961","article-title":"Resistance Profile of Neisseria gonorrhoeae in KwaZulu-Natal, South Africa Questioning the Effect of the Currently Advocated Dual Therapy","volume":"46","author":"Rambaran","year":"2019","journal-title":"Sex. Transm. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e1002499","DOI":"10.1371\/journal.pmed.1002499","article-title":"Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016","volume":"15","author":"Yin","year":"2018","journal-title":"PLoS Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/infdis\/jiab178","article-title":"Dual Azithromycin\/Ceftriaxone Therapy for Gonorrhea in PrEP Cohorts Results in Levels of Macrolide Consumption That Exceed Resistance Thresholds by up to 7-Fold","volume":"224","author":"Kenyon","year":"2021","journal-title":"J. Infect. Dis. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/jac\/dkaa196","article-title":"Sustained transmission of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China","volume":"75","author":"Chen","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1128\/AAC.00504-16","article-title":"New Ceftriaxone- and Multidrug-Resistant Neisseria gonorrhoeae Strain with a Novel Mosaic penA Gene Isolated in Japan","volume":"60","author":"Nakayama","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3201\/eid2404.171873","article-title":"Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain","volume":"24","author":"Lahra","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3201\/eid2402.171756","article-title":"Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017","volume":"24","author":"Lefebvre","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2807\/1560-7917.ES.2017.22.42.17-00659","article-title":"Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017","volume":"22","author":"Terkelsen","year":"2017","journal-title":"Eurosurveillance"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1800617","DOI":"10.2807\/1560-7917.ES.2018.23.47.1800617","article-title":"Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018","volume":"23","author":"Golparian","year":"2018","journal-title":"Eurosurveillance"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1900147","DOI":"10.2807\/1560-7917.ES.2019.24.10.1900147","article-title":"Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018","volume":"24","author":"Eyre","year":"2019","journal-title":"Eurosurveillance"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e02624-18","DOI":"10.1128\/AAC.02624-18","article-title":"First Case of Ceftriaxone-Resistant Multidrug-Resistant Neisseria gonorrhoeae in Singapore","volume":"63","author":"Ko","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/AAC.04320-14","article-title":"Azithromycin Resistance and Its Mechanism in Neisseria gonorrhoeae Strains in Hyogo, Japan","volume":"59","author":"Shigemura","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Jefferson, A., Smith, A., Fasinu, P.S., and Thompson, D.K. (2021). Sexually Transmitted Neisseria gonorrhoeae Infections\u2014Update on Drug Treatment and Vaccine Development. Medicines, 8.","DOI":"10.3390\/medicines8020011"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acsinfecdis.0c00021","article-title":"Zoliflodacin: An Oral Spiropyrimidinetrione Antibiotic for the Treatment of Neisseria gonorrheae, Including Multi-Drug-Resistant Isolates","volume":"6","author":"Bradford","year":"2020","journal-title":"ACS Infect. Dis."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/11\/2\/28\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:07:49Z","timestamp":1760123269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/11\/2\/28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["medsci11020028"],"URL":"https:\/\/doi.org\/10.3390\/medsci11020028","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}